Drugs that target dynamic microtubules: A new molecular perspective
R.A. Stanton, K.M. Gernert, J.H. Nettles, and R. Aneja Drugs that target dynamic microtubules: a new molecular perspective Med. Res. Rev. 31 2011 443 481
Microtubule dynamics: Mechanisms and regulation by microtubule-associated proteins and drugs in vitro and in cells
T. Fojo, Humana Press Totowa
M.A. Jordan, and L. Wilson Microtubule dynamics: mechanisms and regulation by microtubule-associated proteins and drugs in vitro and in cells T. Fojo, The Role of Microtubules in Cell Biology, Neurobiology, and Oncology 2008 Humana Press Totowa 47 81
Tubulin and microtubules as targets for anticancer drug
L. Meijer, A. Jézéquel, M. Roberge, Life in Progress Editions Roscoff
J.A. Hadfield, S. Ducki, N. Hirst, and A.T. McGown Tubulin and microtubules as targets for anticancer drug L. Meijer, A. Jézé quel, M. Roberge, Progress in Cell Cycle Research, Cell Cycle Regulators as Therapeutic Targets vol. 5 2003 Life in Progress Editions Roscoff 309 325
Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells
DOI 10.1016/S0014-5793(02)03478-6, PII S0014579302034786
S. Bu, A. Blaukat, X. Fu, N.E. Heldin, and M. Landstrøm Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells FEBS Lett. 531 2002 141 151 (Pubitemid 35341185)
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site
R.J. D'Amato, C.M. Lin, E. Flynn, J. Folkman, and E. Hamel 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site Proc. Natl. Acad. Sci. U. S. A. 91 1994 3964 3968 (Pubitemid 24139553)
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
DOI 10.1038/368237a0
T. Fotsis, Y. Zhang, M.S. Pepper, H. Adlercreutz, R. Montesano, P.P. Nawroth, and L. Schweigerer The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumour growth Nature 268 1994 237 239 (Pubitemid 24108838)
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer
DOI 10.1158/1078-0432.CCR-05-0440
C. Sweeney, G. Liu, C. Yiannoutsos, J. Kolesar, D. Horvath, M.J. Staab, K. Fife, V. Armstrong, A. Treston, C. Sidor, and G. Wilding A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer Clin. Cancer Res. 11 2005 6625 6633 (Pubitemid 41339003)
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors
W.L. Dahut, N.J. Lakhani, J.L. Gulley, P.M. Arlen, E.C. Kohn, H. Kotz, D. McNally, A. Parr, D. Nguyen, S.X. Yang, S.M. Steinberg, J. Venitz, A. Sparreboom, and W.D. Figg Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors Cancer Biol. Ther. 5 2006 22 27 (Pubitemid 43234973)
Phase i safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
J. James, D.J. Murry, A.M. Treston, A.M. Storniolo, G.W. Sledge, C. Sidor, and K.D. Miller Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer Investig. New Drugs 25 2006 41 48
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma
DOI 10.1158/1078-0432.CCR-07-0807
S.V. Rajkumar, P.G. Richardson, M.Q. Lacy, A. Dispenzieri, P.R. Greipp, T.E. Witzig, R. Schlossman, C.F. Sidor, K.C. Anderson, and M.A. Gertz Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma Clin. Cancer Res. 13 2007 6162 6167 (Pubitemid 350075076)
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma (HCC) cells, and inhibits growth and vascularization in vivo
C. Moser, S.A. Lang, A. Mori, C. Hellerbrand, H.J. Schlitt, E.K. Geissler, W.E. Fogler, and O. Stoeltzing ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma (HCC) cells, and inhibits growth and vascularization in vivo BMC Cancer 8 2008 206 216
ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties
E. Pasquier, S. Sinnappan, M.A. Munoz, and M. Kavallaris ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties Mol. Cancer Ther. 9 2010 1408 1418
Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids
DOI 10.1016/j.bmc.2007.08.017, PII S0968089607006918
S. Aoki, Y. Watanabe, D. Tanabe, M. Arai, H. Suna, K. Miyamoto, H. Tsujibo, K. Tsujikawa, H. Yamamoto, and M. Kobayashi Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids Bioorg. Med. Chem. 15 2007 6758 6762 (Pubitemid 47385240)
Synthesis and anti-angiogenic activity of cortistatin analogs
Y. Sato, H. Kamiyama, T. Usui, T. Saito, H. Osada, S. Kuwahara, and H. Kiyota Synthesis and anti-angiogenic activity of cortistatin analogs Biosci. Biotechnol. Biochem. 72 2008 2992 2997
Stereodivergent synthesis of 17-α and 17-β-aryl steroids: Application and biological evaluation of D-ring cortistatin analogues
J. Shi, H. Shigehisa, C.A. Guerrero, R.A. Shenvi, C.C. Li, and P.S. Baran Stereodivergent synthesis of 17-α and 17-β-aryl steroids: application and biological evaluation of D-ring cortistatin analogues Angew. Chem. Int. Ed. 48 2009 4328 4331
Cortistatin A, B, C and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex
S. Aoki, Y. Watanabe, M. Sanagawa, A. Setiawan, N. Kotoku, and M. Kobayashi Cortistatin A, B, C and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex J. Am. Chem. Soc. 128 2006 3148 3149
Cortistatins E, F, G, and H, four novel steroidal alkaloids from marine sponge Corticium simplex
DOI 10.1016/j.tet.2007.02.112, PII S0040402007003419
Y. Watanabe, S. Aoki, D. Tanabe, A. Setiawan, and M. Kobayashi Cortistatins E, F, G and H, four novel steroidal alkaloids from marine sponge Corticium simplex Tetrahedron 63 2007 4074 4079 (Pubitemid 46533986)
(2007)Tetrahedron, vol.63, Issue.19, pp. 4074-4079
Cortistatins J, K, L, novel abeo-9(10-19)-androstane-type steroidal alkaloids with isoquinoline unit, from marine sponge Corticium simplex
DOI 10.1016/j.tetlet.2007.05.003, PII S004040390700843X
A. Aoki, Y. Watanabe, D. Tanabe, A. Setiawan, M. Arai, and M. Kobyashi Cortistatins J, K, L, novel abeo-9(10-19)-androstane-type steroidal alkaloids with isoquinoline unit, from marine sponge Corticium simplex Tetrahedron Lett. 48 2007 4485 4488 (Pubitemid 46830799)
Enantioselective synthesis of (+)-cortistatin A, a potent and selective inhibitor of endothelial cell proliferation
H.M. Lee, C. Nieto-Oberhuber, and M.D. Shair Enantioselective synthesis of (+)-cortistatin A, a potent and selective inhibitor of endothelial cell proliferation J. Am. Chem. Soc. 130 2008 16864 16866
Total synthesis and biological evaluation of cortistatins A and J and analogues thereof
K.C. Nicolaou, X.S. Peng, Y.P. Sun, D. Polet, B. Zou, C.S. Lim, and D.Y. Chen Total synthesis and biological evaluation of cortistatins A and J and analogues thereof J. Am. Chem. Soc. 131 2009 10587 10597
Scalable synthesis of cortistatin A and related structures
J. Shi, G. Manolikakes, C.H. Yeh, C.A. Guerrero, R.A. Shenvi, H. Shigehisa, and P.S. Baran Scalable synthesis of cortistatin A and related structures J. Am. Chem. Soc. 133 2011 8014 8027
Discovery of potent and practical antiangiogenic agents inspired by cortistatin A
B. Czako, L. Kurti, A. Mammoto, D.E. Ingber, and E.J. Corey Discovery of potent and practical antiangiogenic agents inspired by cortistatin A J. Am. Chem. Soc. 131 2009 9014 9019
Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1
O.W. Akselsen, K. Odlo, J.J. Cheng, G. Maccari, M. Botta, and T.V. Hansen Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1 Bioorg. Med. Chem. 20 2012 234 242
1,2,3-Triazole analogues of combretastatin A-4 as potential microtubule-binding agents
K. Odlo, J. Fournier dit Chabert, S. Ducki, O.A. Gani, I. Sylte, and T.V. Hansen 1,2,3-Triazole analogues of combretastatin A-4 as potential microtubule-binding agents Bioorg. Med. Chem. 18 2010 6874 6885
1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
DOI 10.1016/j.bmc.2008.03.049, PII S0968089608002745
K. Odlo, J. Hentzen, J. Fournier dit Chabert, S. Ducki, O.A. Gani, I. Sylte, M. Skrede, V.A. Flørenes, and T.V. Hansen 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin Bioorg. Med. Chem. 16 2008 4829 4838 (Pubitemid 351625899)
Selective hydrogenation of quinoline and its homologs, isoquinoline, and phenyl-substituted pyridines in the benzene ring
F.W. Vierhapper, and E.L. Eliel Selective hydrogenation of quinoline and its homologs, isoquinoline, and phenyl-substituted pyridines in the benzene ring J. Org. Chem. 40 1975 2729 2734
A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures
J.M. Edmondson, L.S. Armstrong, and A.O. Martinez A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures Tissue Cult. Methods 11 1988 15 17
N.J. Lawrence, A.T. McGown, S. Ducki, and J.A. Hadfield The interaction of chalcones with tubulin Anticancer Drug Des. 15 2000 135 141 (Pubitemid 30410472)
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
M.K. Jones, H. Wang, B.M. Peskar, E. Levin, R.M. Itani, I.J. Sarfeh, and A.S. Tarnawski Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat. Med. 5 1999 1418 1423
Domains regulating transcriptional activity of the inducible orphan receptor NGFI-B
R.E. Paulsen, C.A. Weaver, T.J. Fahrner, and J. Milbrandt Domains regulating transcriptional activity of the inducible orphan receptor NGFI-B J. Biol. Chem. 267 1992 16491 16496
Transfection of chicken cerebellar granule neurons used to study glucocorticoid receptor regulation by nuclear receptor 4A (NR4A)
B.O. Strøm, P. Aden, G.H. Mathisen, J. Lomo, S. Davanger, and R.E. Paulsen Transfection of chicken cerebellar granule neurons used to study glucocorticoid receptor regulation by nuclear receptor 4A (NR4A) J. Neurosci. Methods 193 2010 39 46
